SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-220574
Filing Date
2020-08-14
Accepted
2020-08-14 17:05:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d24456d424b5.htm 424B5 247234
2 GRAPHIC g24456g08i91.jpg GRAPHIC 42650
3 GRAPHIC g24456g45k22.jpg GRAPHIC 76729
  Complete submission text file 0001193125-20-220574.txt   401747
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237033 | Film No.: 201106435
SIC: 2834 Pharmaceutical Preparations